SK Capital Partners, LP announced the final closing of SK Capital Partners VI at $2.95 billion. This fund is the latest vintage of the SK Capital’s Flagship private investment strategy.
Since SK Capital launched in 2007, the firm focused exclusively on transformative investments in the specialty materials, ingredients, and life sciences industries. And with deep operating and investing experience in these sectors, the SK Capital team of 70+ professionals works closely with management teams to transform portfolio companies towards realizing their full potential.
Kirkland & Ellis LLP served as legal advisor, and UBS as placement advisor.
KEY QUOTES:
“We are grateful for the support of our investors as the Firm continues its longstanding mission of building exceptional companies and delivering attractive results. SK Capital has one of the largest and longest-standing teams dedicated to the sectors in which we invest. Together with SKCP Catalyst Fund II, which raised $800 million of total commitments in 2023, the Firm is well-capitalized and well-positioned to continue providing capital solutions to entrepreneurs, families and corporates across all transaction sizes through our unique style of transformative control investing.”
– Barry Siadat, SK Capital’s Co-Founder and Managing Director
“SK Capital is honored to be partnering with such a diverse set of respected and experienced private equity investors. This fundraise exceeded our target while also achieving other fundraising objectives including deepening our relationships with many long-standing partners while also diversifying our investor base globally.”
– SK Capital Managing Director Ben Dillon, who leads the firm’s investor relations, fundraising and co-investment initiatives
